[51] Surprisingly a systematic review and meta-analysis of studies comparing dual antiplatelet (DAPT) with mono-antiplatelet (MAPT) therapy following TAVR, showed a trend toward an increase in 30-day stroke, spontaneous MI, all-cause mortality, and combined lethal and major bleeding with DAPT.
← all excerpts
Transcatheter aortic valve replacement and stroke: a comprehensive review.
1
—
—